Teleflex Incorporated
TFX

$8.27 B
Marketcap
$178.16
Share price
Country
$3.37
Change (1 day)
$256.85
Year High
$171.69
Year Low

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

marketcap

P/E ratio for Teleflex Incorporated (TFX)

P/E ratio as of 2023: 32.87

According to Teleflex Incorporated's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 32.87. At the end of 2022 the company had a P/E ratio of 32.24.

P/E ratio history for Teleflex Incorporated from 1985 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 32.87
2022 32.24
2021 31.65
2020 57.06
2019 37.69
2018 58.81
2017 73.41
2016 29.41
2015 22.31
2014 25.31
2013 25.57
2012 -15.33
2011 7.68
2010 10.68
2009 7.06
2008 16.56
2007 16.89
2006 18.41
2005 19.08
2004 218.11
2003 17.68
2002 13.37
2001 16.31
2000 15.45
1999 12.35
1998 20.33
1997 20.03
1996 16.42
1995 14.91
1994 15.00
1993 18.50
1992 15.98
1991 18.54
1990 12.60
1989 12.66
1988 13.28
1987 12.50
1986 15.35
1985 16.02